Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Start

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.

Previous Story

How the Measles Virus Makes Your Immune System Forget

Next Story

What Can Genes Reveal About Chronic Pain?